Clinical & Experimental Allergy strikes an excellent balance between clinical and scientific articles and carries regular reviews and editorials written by leading authorities in their field. In response to the increasing number of quality submissions, since 1996 the journals size has increased by over 30%. Clinical & Experimental Allergy is essential reading for allergy practitioners and research scientists with an interest in allergic diseases and mechanisms. Truly international in appeal, Clinical & Experimental Allergy publishes clinical and experimental observations in disease in all fields of medicine in which allergic hypersensitivity plays a part. Clinical & Experimental Allergy Reviews is a supplement series publishing the edited proceedings of international meetings and sponsored symposia, position papers, guidelines, special reports, and so on. It is allied to Clinical & Experimental Allergy and included with every subscription to the primary research journal.
Clinical & Experimental Immunology is a top ranking, international journal publishing biologically significant studies that have clinical relevance. The Journal is focused on Translational Immunology and is amongst the foremost journals in this field, attracting high-quality papers from all parts of the world. Translation is viewed as a process of applying ideas, insights and discoveries generated through basic scientific studies to the treatment, prevention or diagnosis of human disease. Journal articles cover clinical studies in patients receiving immune-based therapies, in relation to autoimmunity, primary and secondary immunodeficiencies, complement disorders and allergies. The Journal also reports investigations on the pathogenesis of rheumatic, renal and endocrine disorders, as well as infectious diseases, malignancy and transplantation. Basic immunology studies that inform clinical practice or understanding of disease mechanisms are also welcomed, as are studies in non-human model systems and reports on the physiological mechanisms of immunity. In addition to research reports, the Journal publishes highly cited review, perspective and hypothesis articles. These are usually commissioned and published as Translational Mini-Review series, but suggestions to the Editor-in-Chief of topics for such series, or titles for one-off review articles are welcome. The Journal encourages submission of articles that represent position papers on the classification, diagnosis or treatment of immunological disease.Articles deemed to be of potentially high impact may be drawn to the attention of the Editorial Team for allocation to our Fast-Track category, enabling papers of immediate interest to reach their audience as quickly as possible.Free Access in the Developing WorldFree online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).Online OpenAuthors of articles in this journal can now choose to make their articles open access and available free for all readers through the payment of an author fee.
Clinical & Translational Immunology (CTI) is an open access, fully peer-reviewed journal devoted to publishing cutting-edge advances in biomedical research for scientists and physicians. Brought to you by the editorial team of Immunology & Cell Biology, CTI covers fields including cancer biology, cardiovascular research, gene therapy, immunology, vaccine development and disease pathogenesis and therapy at the earliest phases of investigation.
Now Indexed in PubMed Central.
Clinical Immunology publishes original research on the molecular and cellular bases of immunological disease. The journal also features reviews of timely topics in basic immunology, case reports, and letters to the editor.Research Areas Include:• Ageing• Allergy• Autoimmunity• Biotechnology• Clinical Laboratory Immunology• HIV• Immunodermatology• Immunohematology• Immunotoxicology/Environmental• Infection and Immunity• Mucosal Immunity• Neuroimmunology• Primary Immunodeficiency• Transplantation• Tumor Immunology• VaccinesBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Clinical Infectious Diseases, one of the most heavily cited journals in the fields of infectious diseases and microbiology, publishes articles on diverse topics in infectious diseases, with a focus on clinical practice. Every issue includes special sections focusing on key topics such as HIV/AIDS, antimicrobial resistance, aging and infectious diseases, and biological weapons. Many articles are published with commentaries by prominent researchers, and current trends and best practices are regularly covered in review articles and practice guidelines. CID also publishes numerous supplements devoted to single topics in the field.
Clinical Microbiology Reviews® analyzes the latest developments in clinical microbiology and immunology. Key topics include pathogenic mechanisms, individual and groups of microbial pathogens, clinical and laboratory aspects of newly recognized and reemerging infectious diseases, antimicrobial agents and their applications, and diagnostic laboratory technologies.
Clinical Microbiology and Infection (CMI) is a monthly publication in English of the European Society of Clinical Microbiology and Infectious Diseases and publishes peer-reviewed papers that present basic and applied research relevant to therapy and diagnostics in the fields of microbiology, infectious diseases, virology, parasitology, immunology and epidemiology.
The development of clinical allergy as a discipline of scientific medicine has, until recently, lagged behind that of other subspecialties in internal medicine and pediatrics. The discovery of immunoglobulin E, the development of standardized protocols for allergy skin testing and challenge procedures, and concurrent advances in cell biology have all led to a major thrust by new data in changing the approach to the clinical management of allergic disease. The object of this journal is to publish scholarly review papers, with each issue devoted to a single theme, in an attempt to provide comprehensive treatment of a subject of critical importance to allergists. The journal publishes both experimental papers and comprehensive treatises placing new data in perspective. The ultimate objective is to help improve the care and management of patients with allergic disease.
Clinical and Molecular Allergy publishes research on all clinical and molecular aspects of allergic (Type 1 hypersensitivity) and primary immunodeficiency disorders (diseases that alter host defense but are not related to Human Immunodeficiency Virus infection). Studies of allergic or hypersensitive aspects of HIV infection/AIDS or drug desensitization protocols in AIDS, however, fall into the journal’s scope.
Clinical and Translational Allergy is a peer reviewed open access journal aiming to provide a platform to publish original research and reviews in the field of allergy. Such papers can be based on clinical, translational or basic research. Clinical and Translational Allergy is one of several journals in the portfolio of the European Academy of Allergy and Clinical Immunology.
Based on the concept of "One World, One Health, One Medicine", interdisciplinary cooperation between specialists in human and animal medicine is of mutual interest and benefit. Therefore, there is need to combine the respective interest of physicians, veterinarians and other health professionals for comparative studies relevant to either human or animal medicine.Comparative Immunology, Microbiology & Infectious Diseases aims to respond to this concept of "One World, One Health, One Medicine" and to provide a venue for scientific exchange.The journal is open to subjects of common interest related to the immunology, immunopathology, microbiology and epidemiology of human and animal infectious diseases, especially zoonotic infections, and animal models of human infectious diseases. The role of environmental factors in disease emergence is emphasized.Original research papers of high quality and novelty on aspects of host response, molecular biology, pathogenesis, control and prevention and treatment of microbial diseases of domestic animals and wildlife (if the infections are of zoonotic interest and/or in relation with domestic animals), laboratory animals and animal models of human infections are considered for publication. Papers dealing primarily with epidemiology will only be considered if they demonstrate a clear impact on the pathogenesis or prevention of a disease. Similarly, articles addressing microbiology, immunology or pathogenesis must address issues of comparative medical interest.Review articles are highly appreciated. They should focus either on a pathogen or on analyses of the mechanisms of host-microbe interactions including epidemiological studies.Papers focusing solely on diagnostic techniques, case reports or drug trials will not be published. Papers of geographically limited interest, which repeat what had been established elsewhere, will not be considered. The readership of the journal is global. The Editors reserve the right to suggest submission to another journal for those papers which they feel would be more appropriate for consideration by that journal.Papers will be rejected if standards of care of, or procedures performed on animals are not beyond those expected of humane veterinary care. Standards must, at least, meet the International Guiding Principles for Biomedical Research involving Animals, as issued by the Council for International Organizations of Medical Sciences. (C.I.O.M.S., c/o WHO, CH 1211 Geneva 27, Switzerland).
The Comptes rendus Biologies publish monthly communications dealing with all biological and medical research fields (biological modelling, development and reproduction biology, cell biology, biochemistry, neurosciences, immunology, pharmacology, ecology, etc.).Articles are preferably written in English. Articles in French with an abstract in English are accepted.
Coronaviruses publishes original research articles, letters, reviews/mini-reviews, clinical trial and guest edited thematic issues on all aspects of coronaviruses such as their origins, types, transmission, pathogenesis, epidemiological, demographic, clinical and genomic characteristics etc.
The Journal also covers case reports and studies on outbreak of coronaviruses, their symptoms, related diseases, prevention, treatment and development of new therapeutics.